Sector | Healthcare | Compare with Sector peers |
Industry | Medical Equipment/Supplies/Accessories | Compare with Industry peers |
Website | http://www.transpact.in | |
Market Cap | 15.24 Cr. | |
Enterprise Value(EV) | 15.27 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -1.70 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-03 |
Industry PE | 58.10 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 13.79 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 28.58 | Calculated using Price: 394.20 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.04 Cr. | 386,730 Shares |
FaceValue | 10 | |
About Transpact Enterprises Ltd. | ||
Transpact Enterprises, Maharashtra based is a biotechnology startup. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products. Transpact Enterprises mainly designs, develops and distributes Vestibulator, a therapeutic device. The device has been invented by the Society for Innovation and Entrepreneurship, lIT Bombay. And, Transpact Enterprises holds a license to carry out the commercial activities of Vestibulator. It is a co-patented technology of the company and IRCC-IIT Bombay. The company outsources the manufacturing of the device along with the design details to a 3rd party. With the help of advanced software, the company also offers customized device solutions for patients. |
1 Day |
|
|
1 Week |
|
-4.99% |
1 Month |
|
-4.99% |
3 Month |
|
+10.58% |
6 Month |
|
+97.20% |
1 Year |
|
+314.95% |
2 Year |
|
+165.81% |
5 Year |
|
|
10 Year |
|
7 years | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -27.59 | -77.28 | -804.02 | -97.83 | -7.53 | -31.12 | -11.64 | |
Return on Capital Employed (%) | -19.45 | -27.62 | -66.2 | -53.57 | -5.23 | -21.88 | -7.88 | |
Return on Assets (%) | -19.19 | -25.93 | -60.34 | -47.48 | -4.78 | -17.8 | -6.14 |
Particulars | 8 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | |||
Curr. Liab. | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
Minority Int. | |||||||||
Equity & Liab. | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |
Non Curr. Assets | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | |
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Misc. Exp. not W/O | |||||||||
Total Assets | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 0 | 0 | 0 | 0 | ||||
Other Income | 0 | 0 | 0 | |||||
Total Income | 0 | 0 | 0 | 0 | 0 | |||
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | ||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | |||
Taxation | 0 | 0 | 0 | |||||
Exceptional Items | ||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | -2 | -3 | -11 | -11 | -2 | -6 | -2 |
Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -1 | 0 | -1 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | |||||
Cash Fr. Finan. | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
Net Change | 0 | 0 | 0 | -1 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
Sat, 23 Mar 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer Additional Details required under SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13 2023 for Corporate Announcement regarding Resignation of Company Secretary |
Wed, 20 Mar 2024
Shareholder Meeting - EGM On April 12 2024 (Friday) Extraordinary General Meeting to be held on Friday April 12 2024 at 11.00 A.M. through Video Conference (VC)/ Other Audio- Visual Means (OAVM) |
Fri, 15 Mar 2024
Appointment of Company Secretary and Compliance Officer Appointment of Ms. Amrita Gupta (ACS No. 44487) as the Company Secretary and Compliance officer of the Company |
Wed, 27 Mar 2024 |
Higher Delivery Quantity |
Higher Trade Quantity |
Higher Trade and Delivery Quantity |
Close Crossing Last Month Low |
Close Crossing Last Month Close from Above |